EXEL
Exelixis Inc
Price:  
21.91 
USD
Volume:  
2,586,317.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXEL Relative Valuation

-10.5%
Upside

As of 2024-02-29, the Relative Valuation of Exelixis Inc (EXEL) is 19.60 USD. This relative valuation is based on P/E multiples. With the latest stock price at 21.91 USD, the upside of Exelixis Inc based on Relative Valuation is -10.5%.

The range of the Relative Valuation is 16.73 - 21.35 USD.

Range Selected
Trailing P/E multiples 29.2x - 31.2x 30.5x
Forward P/E multiples 23.4x - 26.7x 25.6x
Fair Price 16.73 - 21.35 19.60
Upside -23.6% - -2.6% -10.5%
21.91 USD
Stock Price
19.60 USD
Fair Price

EXEL Relative Valuation - Historical P/E Data

Date P/E
2024-02-28 31.98
2024-02-27 31.69
2024-02-26 32.05
2024-02-23 31.43
2024-02-22 30.23
2024-02-21 30.24
2024-02-20 30.11
2024-02-16 29.89
2024-02-15 30.05
2024-02-14 29.76
2024-02-13 29.53
2024-02-12 29.76
2024-02-09 29.51
2024-02-08 29.44
2024-02-07 29.46
2024-02-06 31.86
2024-02-05 31.24
2024-02-02 31.37
2024-02-01 31.75
2024-01-31 31.76
2024-01-30 31.95
2024-01-29 31.95
2024-01-26 32.29
2024-01-25 32.24
2024-01-24 32.27
2024-01-23 33.00
2024-01-22 33.05
2024-01-19 32.81
2024-01-18 32.51
2024-01-17 32.90
2024-01-16 32.90
2024-01-12 33.13
2024-01-11 32.71
2024-01-10 33.37
2024-01-09 33.97
2024-01-08 32.90
2024-01-05 33.92
2024-01-04 34.46
2024-01-03 34.65
2024-01-02 34.93
2023-12-29 35.02
2023-12-28 35.22
2023-12-27 35.10
2023-12-26 35.06
2023-12-22 34.94
2023-12-21 34.27
2023-12-20 33.89
2023-12-19 34.80
2023-12-18 34.07
2023-12-15 34.17